Qingsong Liu
Affiliations: | Chinese Academic Science, High Magnetic Field Laboratory |
Area:
Translation medicineGoogle:
"Qingsong Liu"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hu J, Liu J, Zou F, et al. (2025) Repurposing of clinical-stage FLT3 inhibitor HYML-122 as a potent RIPK2 inhibitor for the treatment of inflammatory bowel disease. International Immunopharmacology. 159: 114839 |
| Qi S, Cao J, Wu T, et al. (2025) Discovery of IHMT-15130 as a Highly Potent Irreversible BMX Inhibitor for the Treatment of Myocardial Hypertrophy and Remodeling. Acs Chemical Biology |
| Shi C, Wu Y, Zou F, et al. (2025) Discovery of a Novel Dihydroisoquinolinone Derivative as a Potent CDK9 Inhibitor Capable of Overcoming L156F Mutant for the Treatment of Hematologic Malignancies. Journal of Medicinal Chemistry |
| Jiao CQ, Hu C, Sun MH, et al. (2025) Targeting METTL3 mitigates venetoclax resistance via proteasome-mediated modulation of MCL1 in acute myeloid leukemia. Cell Death & Disease. 16: 233 |
| Wang C, Zou F, Qi Z, et al. (2024) Discovery of Pyrazolo[1,5-]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors. Journal of Medicinal Chemistry |
| Zhou B, Wang B, Zou F, et al. (2023) Discovery of dihydropyridinone derivative as a covalent EZH2 degrader. European Journal of Medicinal Chemistry. 261: 115825 |
| Hu C, Shen L, Zou F, et al. (2023) Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy. Acta Pharmaceutica Sinica. B. 13: 3694-3707 |
| Liang X, Deng M, Zou F, et al. (2023) Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3Kγ/δ dual inhibitor. European Journal of Medicinal Chemistry. 260: 115768 |
| Liang Q, Wang B, Zou F, et al. (2023) Structure-based discovery of IHMT-IDH1-053 as a potent irreversible IDH1 mutant selective inhibitor. European Journal of Medicinal Chemistry. 256: 115411 |
| Wang A, Liu J, Li X, et al. (2023) Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment. European Journal of Pharmacology. 175752 |